Jordi Cámara
- Microbiology top 1%
- Bacterial Infections and Vaccines 10
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 6
- Microbiology top 5%
- Bacterial Infections and Vaccines 10
- Clinical Biochemistry top 5%
-
- Pneumonia and Respiratory Infections 16
- Pneumocystis jirovecii pneumonia detection and treatment 8
-
- Antimicrobial Resistance in Staphylococcus 10
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 4
-
- Streptococcal Infections and Treatments 8
- Co-authors
- Carmen ArdanuyJosefina AyatsAntònia AndreuDolors Carnicer-PontJ SerraFé TubauM.Á. DomínguezAída González-Díaz
- Cited by
- MicrobiologyMolecular Medicine
- Journals
- Journal of Antimicrobial Chemotherapy (7 papers)International Journal of Infectious Diseases (2 papers)Eurosurveillance (2 papers)
- Partner nations
- SpainFranceUnited States
In The Last Decade
Jordi Cámara
43 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 97
- Microbiology 403
- Molecular Medicine 222
- Microbiology 30
- Applied Microbiology and Biotechnology 73
- Clinical Biochemistry 84
Countries citing papers authored by Jordi Cámara
This map shows the geographic impact of Jordi Cámara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Cámara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Cámara more than expected).
Fields of papers citing papers by Jordi Cámara
This network shows the impact of papers produced by Jordi Cámara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Cámara. The network helps show where Jordi Cámara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jordi Cámara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 26 | |
| 6 | 2022 | 37 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 6 | |
| 17 | 2019 | 31 | |
| 18 | 2019 | 14 | |
| 19 | 2018 | 20 | |
| 20 | 2008 | 8 |
About Jordi Cámara
Jordi Cámara is a scholar working on Microbiology, Applied Microbiology and Biotechnology and Microbiology, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (16 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Infections and Vaccines (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Streptococcal Infections and Treatments (8 papers), Antibiotic Resistance in Bacteria (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and SARS-CoV-2 detection and testing (4 papers). The work is most often cited by research in Microbiology (403 citations), Molecular Medicine (222 citations) and Microbiology (30 citations). Jordi Cámara has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Carmen Ardanuy, Josefina Ayats, Antònia Andreu, Dolors Carnicer-Pont, J Serra, Fé Tubau, M.Á. Domínguez, Aída González-Díaz, Meritxell Cubero and Jordi Carratalà. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Infectious Diseases, Eurosurveillance, International Journal of Antimicrobial Agents and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.